Behavioral Interventions as Primary Prevention for Non-Communicable Diseases Among Young People

Behavioral Interventions as Primary Prevention for Non-Communicable Diseases Among Young People; a Randomized Clinical Trial

In consistence of North Africa vision to decrease incidence of NCDs in different population type investigators decide to give more concerns to youth (young old) who are the main human power to build future. Recent data report non-communicable diseases (NCDs) are the current leading cause of mortality in Egypt, with NCDs estimated to account for 85% of all deaths. Egypt's youth population (16-25 years old) is both the country's greatest asset and one of its biggest challenges. This age group makes up a huge share of the population, and while they are more connected to technology, social media, and modern facilities than older generations, they face lifestyle barriers that affect their health and productivity. Many modifiable risk factors affect their behavior and in consequence health. These factors related strongly to their close relationship with technology, they spend more time on mobile and computer applications that affect directly on physical inactivity, sleeping time (onset and duration) and at the end cause NCDs as obesity and CVs problems. Upper Egypt as apart from North Africa region is considered as one of the low-income countries with special cultures, specifically regarding food and physical activities. Even though young people constitute a significant proportion of the population, comparatively fewer studies have examined the prevalence of health concerns and the strategies needed to promote their well-being, especially when contrasted with research focused on groups such as the elderly or pregnant and lactating women. This project aims to investigate prevalence patterns, identify contributing factors, enhance community awareness by encouraging training of healthcare providers to best act and modify youth risk factors, and implement preventive interventions that are both cost-effective and sustainable. Furthermore, it seeks to foster adherence to these measures to strengthen health literacy and reduce the burden of conditions

Study Overview

• Status: Not yet recruiting
• Conditions: Non Communicable Diseases; Non Communicable Chronic Diseases
• Intervention / Treatment: Behavioral: health education of preventive tools for developing chronic diseases

• Study Type: Interventional
• Enrollment (Estimated): 2000
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Minya, Egypt, 05673
    • Deraya university

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Age Range: Typically 10-19 (adolescents) or 15-24 (young adults).
• resident in Egypt
• accept sharing and adhered for following
• At-risk youth (e.g., sedentary, high-sugar diet)
• Motivated to use digital tools
• Diverse socio-economic backgrounds
• Healthy enough for moderate exercise
• Presence of at least one modifiable risk factor, such as:

Insufficient physical activity (not meeting WHO guidelines of 60 min/day). Unhealthy dietary habits (high sugar/salt intake, low fruit/vegetable consumption).

Tobacco use or exposure to second-hand smoke (including vaping). Harmful alcohol consumption patterns.

Exclusion Criteria:

• Individuals already diagnosed with the NCDs being targeted
• Presence of medical conditions that cause secondary obesity or hypertension
• Current use of medications that significantly affect metabolic or behavioral outcomes
• Individuals with active psychosis, severe clinical depression, or eating disorders
• Severe impairments that prevent the individual from understanding the study requirements, providing informed assent, or interacting with digital intervention tools
• Enrollment in another clinical trial or behavioral intervention that might lead to "treatment contamination."
• Unable to consent or use tech due to severe deficit
• Temporary residents (will move before data collection ends)
• Safety risk (e.g., severe heart condition)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: behavior therapy	Behavioral: health education of preventive tools for developing chronic diseases; User Experience (UX) / User Interface (UI) design followed by rapid prototyping. Integration of Behavioral Change Techniques (BCTs) like nudging, peer-to-peer rewards, and goal setting
No Intervention: Control group; Normal life style

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
BMI control	Measurements of BMI, before weigh/length square after 6 months and 1 year from following in the program	6-12 months

Secondary Outcome Measures

Outcome Measure	Time Frame
Blood pressure contrl	6-12 months
Blood glucose levels	6_12 months

Other Outcome Measures

Outcome Measure	Time Frame
Smoking cessation	6-12 months

Collaborators and Investigators

• Sponsor: Deraya University

Study record dates

Study Major Dates

• Study Start (Estimated): April 1, 2026
• Primary Completion (Estimated): April 1, 2027
• Study Completion (Estimated): January 1, 2028

Study Registration Dates

• First Submitted: March 30, 2026
• First Submitted That Met QC Criteria: April 9, 2026
• First Posted (Actual): April 14, 2026

Study Record Updates

• Last Update Posted (Actual): April 17, 2026
• Last Update Submitted That Met QC Criteria: April 14, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Keywords: young adults; non communicable diseases; behaviour intervention
• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Pathological Conditions, Signs and Symptoms; Noncommunicable Diseases
• Other Study ID Numbers: April 2026

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No